cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25919/z2a5-5b47
title: Parkes observations for project P595 semester 2025APRS_33

description: We propose to continue the PULSE@Parkes project in which high school students from Australia and around the World use the Parkes radio telescope in a remote observing model to observe and analyse pulsar data. The data from some PULSE@Parkes observations are used to support the space missions, other observations supplement the P456 Pulsar Timing Array project and the remainder were chosen in order to make a detailed analysis of pulsar timing irregularities and intermittency.
DOI: 10.15468/dl.bfdyer
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruscus hypophyllum",
 "Country is Malta",
 "HasCoordinate is true"
 ]
}

 The dataset includes 4 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037529-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/pr00011815
title: BRF117277: A Phase II, Open-Label, Multicentre Study of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

description: This is a multi-cohort, open label, Phase II study with Dabrafenib (GSK2118436) and Trametinib (GSK1120212) combination therapy in subject with BRAF mutation-positive melanoma that has metastasized to the brain. This study will evaluate the safety and efficacy of 4 cohorts. Cohorts will consist of; V600 E, D, K, R mutations, metastases to the brain, symptomatic and asymptomatic, with or without prior local (brain) therapy, with or without prior local (brain) therapy, and range of ECOG scores from 0-2.
DOI: 10.25934/pr00011816
title: A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care

description: This low interventional study, whose unique intervention was to measure the blood level of a biomarker called NT-proBNP in chronic heart failure patients daily followed-up by Primary Care Physicians (PCPs) in Europe, assessed if the cardiologist referral guided by NT-proBNP measurement in patients who were currently judged by PCPs as being stable, would lead to optimization of HF treatment, defined in adherence to treatment recommendations of the current European Society of Cardiology guidelines for the treatment of heart failure.
DOI: 10.25934/pr00011817
title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Two-period Cross-over Study to Assess the Effect of 50µg Inhaled NVA237 on Exercise Endurance in Patients With Moderate to Severe COPD

description: The ability for patients with COPD to exercise is limited due to the deterioration of their lung function. NVA237 is being developed to treat COPD. This study is designed to look at how well NVA237 improves the ability to exercise in patients with moderate to severe COPD.
DOI: 10.25934/pr00011818
title: A Phase III Randomized, Double-blind, Placebo-controlled, 2-period Crossover, Multicenter Study to Assess the Effect of Indacaterol (300 μg o.d.) on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

description: This study compared the effect of indacaterol (300 μg once daily \[od\]) on exercise endurance with that of placebo in patients with moderate to severe chronic obstructive pulmonary disease.
DOI: 10.25934/pr00011819
title: A Randomized, Blinded, Double Dummy, Multi-center, Placebo Controlled, 3 Period, Crossover Study to Assess the Effect of QVA149 (110/50 µg o.d.) on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control.

description: This study assessed the effect of once-daily indacaterol and glycopyrronium bromide (QVA149) on exercise endurance in patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
DOI: 10.25934/pr00011820
title: A Randomized, Double-blind, Multi-center Phase III Study Comparing Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Gastric Cancer After Progression on 1 or 2 Prior Systemic Chemotherapy

description: This study is designed to assess the safety and efficacy of RAD001 monotherapy in patients with advanced gastric cancer which has progressed after one or two lines of prior chemotherapy.
DOI: 10.25934/pr00011821
title: A Multicenter, Randomized, Double Blind, Placebo Controlled Phase III Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma

description: Panobinostat (LBH589) is a highly potent pan-deacetylase inhibitor (pan-DACi), inclusive of HDAC6, which disrupts aggresome function, promotes accumulation of cytotoxic misfolded protein aggregates and triggers myeloma cell death. Combination of pan-DAC and protease inhibition by co-treatment with panobinostat (PAN) and bortezomib (BTZ) has demonstrated synergistic cytotoxicity in vitro and in vivo in pre-clinical experiments. Furthermore, clinical experience in advanced multiple myeloma (MM) patients treated by oral panobinostat and i.v bortezomib ± dexamethasone showed very encouraging results for efficacy and manageable toxicity profile.Given the medical need for improved treatment strategies for patients with previously treated and relapsed MM, the purpose of this prospective, multinational, randomized, double-blind, placebo-controlled, parallel group Phase III study is to compare the results in progression-free survival of 2 combination therapies, panobinostat with bortezomib and dexamethasone or placebo with bortezomib and dexamethasone, in patients with previously treated MM whose disease has recurred or progressed.
DOI: 10.25934/pr00011822
title: A 24-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Evaluation of the Efficacy, Safety, and Tolerability of the Once-daily Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease (MMSE 10-20)

description: The purpose of this study was to investigate the 5cm\^2 and 10cm\^2 doses of rivastigmine transdermal patch in terms of efficacy and safety in patients with probable Alzheimer's Disease (MMSE \[Mini Mental State Examination\] 10-20). A 52-week extension phase evaluated the safety and tolerability of long-term treatment by rivastigmine transdermal patch in patients with probable Alzheimer's Disease (AD).
DOI: 10.25934/pr00011823
title: A 24-month, Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of Fingolimod 1.25 mg and 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis

description: This study assessed the efficacy, safety, and tolerability of 2 doses of oral fingolimod (1.25 mg/day and 0.5 mg/day) compared to placebo in patients with relapsing-remitting multiple sclerosis (RRMS)
DOI: 10.25934/pr00011824
title: Neoadjuvant Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer. A Randomized Open Phase II Trial Evaluating the Efficacy of a 6 Months Preoperative Treatment With Letrozole (2.5 mg/Day) With or Without Zoledronic Acid (4 mg Every 4 Weeks)

description: This study will evaluate the safety/efficacy of zoledronic acid when given by intravenous infusion every 4 weeks in addition to letrozole as endocrine therapy in postmenopausal patients with hormone responsive breast cancer
DOI: 10.25934/pr00011825
title: A 64-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Effect of QVA149 (110/50 μg o.d.) vs NVA237 (50 μg o.d.) and Open-label Tiotropium (18 μg o.d.) on COPD Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

description: This study is designed to assess the effect of once-daily QVA149 on COPD exacerbations in patients with severe to very severe COPD.
DOI: 10.25934/pr00011826
title: A 52-week Treatment, Multi-center, Randomized, Open Label, Parallel Group Study to Assess the Long Term Safety and Tolerability of QVA149 (110 Mcg Indacaterol / 50 Mcg Glycopyrrolate o.d.) Using Tiotropium (18 Mcg o.d.) as an Active Control in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

description: This is a 52-week treatment, multi-center, randomized, open label, parallel group study to assess the long term safety and tolerability of once-daily QVA149 (indacaterol and NVA237 (\[glycopyrronium bromide\]) using tiotropium as an active control in Japanese patients with moderate to severe chronic obstructive pulmonary disease (COPD).
DOI: 10.25934/pr00011827
title: A Phase II Study of Lapatinib for Brain Metastases in Subjects With ErbB2-Positive Breast Cancer Following Trastuzumab-based Systemic Therapy and Cranial Radiotherapy

description: Determine how safe and effective lapatinib is when used to treat patients with ErbB2 overexpressing breast cancer that has spread to the brain and is still progressing there even after radiation treatment using WBRT (whole brain radiotherapy) or SRS (stereotactic radiosurgery) to the brain. Lapatinib is an oral drug that will be taken every day. Tests for safety and efficacy will be performed every 4 weeks or 8 weeks (depending on the test) during the course of the study.
DOI: 10.25934/pr00011828
title: A Randomized, Double-blind, Placebo Controlled, Multicenter Dose Ranging Study of Subcutaneously Administered AIN457, Assessing Psoriasis Area and Severity Index (PASI) Response in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

description: The purpose of the study is to determine whether, in patients with moderate to severe plaque-type psoriasis, AIN457 administered subcutaneously reduces the severity of psoriasis symptoms and the extent to which the patient's body area is affected by the disease (compared to placebo).
DOI: 10.15468/dl.94w55c
title: Occurrence Download

description: A dataset containing 536 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Vespidae",
 "Year is 1900",
 "Continent is Europe",
 "HasCoordinate is true"
 ]
}

 The dataset includes 536 records from 20 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037530-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.tzt3uq
title: Occurrence Download

description: A dataset containing 2 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruscus hypophyllum",
 "Country is Netherlands",
 "HasCoordinate is true"
 ]
}

 The dataset includes 2 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037531-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.xv24r8
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruscus hypophyllum",
 "Country is Portugal",
 "HasCoordinate is true"
 ]
}

 The dataset includes 4 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037532-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.53c7p3
title: Occurrence Download

description: A dataset containing 39273 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Pulsatrix perspicillata"
 ]
}

 The dataset includes 39273 records from 179 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037533-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.17246556
title: Industrial and Commercial Electricity Tariffs in the United States

description: We use a data format specified by Chapin et al. in 'Electricity and natural gas tariffs at United States wastewater treatment plants' that can represent all the complexities of electricity tariffs across the United States (tiered charges, multiple peak periods, daily demand charges, etc.).
DOI: 10.15468/dl.84uv86
title: Occurrence Download

description: A dataset containing 6 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Vespidae",
 "Year is 1900",
 "Continent is North America",
 "HasCoordinate is true"
 ]
}

 The dataset includes 6 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037534-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.3840615
title: Dataset of Concurrent EEG, ECG, and Behavior with Multiple Doses of transcranial Electrical Stimulation-Exp1-Data Downsampled

description: GX Dataset downsampled - Experiment 1


The GX Dataset is a dataset of combined tES, EEG, physiological, and behavioral signals from human subjects.
Here the GX Dataset for Experiment 1 is downsampled to 1 kHz and saved in .MAT format which can be used in both MATLAB and Python.


Publication


A full data descriptor is published in Nature Scientific Data. Please cite this work as:


Gebodh, N., Esmaeilpour, Z., Datta, A. et al. Dataset of concurrent EEG, ECG, and behavior with multiple doses of transcranial electrical stimulation. Sci Data 8, 274 (2021). https://doi.org/10.1038/s41597-021-01046-y


 


Descriptions


A dataset combining high-density electroencephalography (EEG) with physiological and continuous behavioral metrics during transcranial electrical stimulation (tES). Data includes within subject application of nine High-Definition tES (HD-tES) types targeted three brain regions (frontal, motor, parietal) with three waveforms (DC, 5Hz, 30Hz), with more than 783 total stimulation trials over 62 sessions with EEG, physiological (ECG, EOG), and continuous behavioral vigilance/alertness metrics.


Acknowledgments


Portions of this study were funded by X (formerly Google X), the Moonshot Factory. The funding source had no influence on study conduction or result evaluation. MB is further supported by grants from the National Institutes of Health: R01NS101362, R01NS095123, R01NS112996, R01MH111896, R01MH109289, and (to NG) NIH-G-RISE T32GM136499.


Extras


Back to Full GX Dataset : https://doi.org/10.5281/zenodo.4456079


 


For downsampled data (1 kHz ) please see (in .mat format):



	
Experiment 1 : https://doi.org/10.5281/zenodo.3840615 
	
Experiment 2 : https://doi.org/10.5281/zenodo.3840617 



 


Code used to import, process, and plot this dataset can be found here:



	
GitHub : https://github.com/ngebodh/GX_tES_EEG_Physio_Behavior



 


Additional figures for this project have been shared on Figshare. Trial-wise figures can be found here:



	
PSD: https://doi.org/10.6084/m9.figshare.14810517.v1
	
Topoplots During Stimulation: https://doi.org/10.6084/m9.figshare.14810478
	
Voltage timeseries, spectrogram and behavior: https://doi.org/10.6084/m9.figshare.14810442.v1



 


The full dataset is also provided in BIDS format here:



	
Data in BIDS format: https://doi.org/10.18112/openneuro.ds003670.v1.1.0



Data License 
Creative Common 4.0 with attribution (CC BY 4.0)


 


NOTE


Please email ngebodh01@citymail.cuny.edu with any questions.


Follow @NigelGebodh for latest updates.
DOI: 10.15468/dl.78m29n
title: Occurrence Download

description: A dataset containing 5431 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Colombia",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Pulsatrix perspicillata"
 ]
}

 The dataset includes 5431 records from 81 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037536-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.frdy6a
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruscus microglossus",
 "Country is Croatia",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037537-250920141307145/datasets/export for details.
DOI: 10.15468/dl.qducck
title: Occurrence Download

description: A dataset containing 10 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Ruscus microglossus",
 "Country is France",
 "HasCoordinate is true"
 ]
}

 The dataset includes 10 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037538-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.p7z6bk
title: Occurrence Download

description: A dataset containing 35563 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is United States of America",
 "OccurrenceStatus is Present",
 "TaxonKey is Didelphis virginiana",
 "Year 2017-2025"
 ]
}

 The dataset includes 35563 records from 36 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0037539-250920141307145/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25574/25724
title: Chandra X-ray Observatory ObsId 25724

description: Illuminating a massive node in the Cosmic Web at redshift 3
DOI: 10.34740/kaggle/dsv/13231068
title: Peer-to-Peer Boliviano (BOB) Exchange Data
DOI: 10.5281/zenodo.3840614
title: Dataset of Concurrent EEG, ECG, and Behavior with Multiple Doses of transcranial Electrical Stimulation-Exp1-Data Downsampled

description: GX Dataset downsampled - Experiment 1

The GX Dataset is a dataset of combined tES, EEG, physiological, and behavioral signals from human subjects.Here the GX Dataset for Experiment 1 is downsampled to 1 kHz and saved in .MAT format which can be used in both MATLAB and Python.

Publication

A full data descriptor is published in Nature Scientific Data. Please cite this work as:



Gebodh, N., Esmaeilpour, Z., Datta, A. et al. Dataset of concurrent EEG, ECG, and behavior with multiple doses of transcranial electrical stimulation. Sci Data 8, 274 (2021). https://doi.org/10.1038/s41597-021-01046-y


Descriptions

A dataset combining high-density electroencephalography (EEG) with physiological and continuous behavioral metrics during transcranial electrical stimulation (tES). Data includes within subject application of nine High-Definition tES (HD-tES) types targeted three brain regions (frontal, motor, parietal) with three waveforms (DC, 5Hz, 30Hz), with more than 783 total stimulation trials over 62 sessions with EEG, physiological (ECG, EOG), and continuous behavioral vigilance/alertness metrics.

Acknowledgments

Portions of this study were funded by X (formerly Google X), the Moonshot Factory. The funding source had no influence on study conduction or result evaluation. MB is further supported by grants from the National Institutes of Health: R01NS101362, R01NS095123, R01NS112996, R01MH111896, R01MH109289, and (to NG) NIH-G-RISE T32GM136499.

Extras

Back to Full GX Dataset : https://doi.org/10.5281/zenodo.4456079

 

For downsampled data (1 kHz ) please see (in .mat format):



Experiment 1 : https://doi.org/10.5281/zenodo.3840614

Experiment 2 : https://doi.org/10.5281/zenodo.3840616


 

Code used to import, process, and plot this dataset can be found here:



GitHub : https://github.com/ngebodh/GX_tES_EEG_Physio_Behavior


 

Additional figures for this project have been shared on Figshare. Trial-wise figures can be found here:



PSD: https://doi.org/10.6084/m9.figshare.14810517.v1

Topoplots During Stimulation: https://doi.org/10.6084/m9.figshare.14810478

Voltage timeseries, spectrogram and behavior: https://doi.org/10.6084/m9.figshare.14810442.v1


 

The full dataset is also provided in BIDS format here:



Data in BIDS format: https://doi.org/10.18112/openneuro.ds003670.v1.1.0


Data License Creative Common 4.0 with attribution (CC BY 4.0)

 

NOTE

Please email ngebodh01@citymail.cuny.edu with any questions.

 

Updates



Version 2.1.0



Behavioral data (ptracker) adjusted for all files. Previous version had one participant's data overwriting all behavioral data when downsampled. Mat format now explicitly >v7.3  



Version 2 



Stimulation trigger labels now adjusted. Previous labels were missmatched for Experiment 1's data.
DOI: 10.5281/zenodo.8401160
title: Dataset of Concurrent EEG, ECG, and Behavior with Multiple Doses of transcranial Electrical Stimulation-Exp1-Data Downsampled

description: GX Dataset downsampled - Experiment 1


The GX Dataset is a dataset of combined tES, EEG, physiological, and behavioral signals from human subjects.
Here the GX Dataset for Experiment 1 is downsampled to 1 kHz and saved in .MAT format which can be used in both MATLAB and Python.


Publication


A full data descriptor is published in Nature Scientific Data. Please cite this work as:


Gebodh, N., Esmaeilpour, Z., Datta, A. et al. Dataset of concurrent EEG, ECG, and behavior with multiple doses of transcranial electrical stimulation. Sci Data 8, 274 (2021). https://doi.org/10.1038/s41597-021-01046-y


 


Descriptions


A dataset combining high-density electroencephalography (EEG) with physiological and continuous behavioral metrics during transcranial electrical stimulation (tES). Data includes within subject application of nine High-Definition tES (HD-tES) types targeted three brain regions (frontal, motor, parietal) with three waveforms (DC, 5Hz, 30Hz), with more than 783 total stimulation trials over 62 sessions with EEG, physiological (ECG, EOG), and continuous behavioral vigilance/alertness metrics.


Acknowledgments


Portions of this study were funded by X (formerly Google X), the Moonshot Factory. The funding source had no influence on study conduction or result evaluation. MB is further supported by grants from the National Institutes of Health: R01NS101362, R01NS095123, R01NS112996, R01MH111896, R01MH109289, and (to NG) NIH-G-RISE T32GM136499.


Extras


Back to Full GX Dataset : https://doi.org/10.5281/zenodo.4456079


 


For downsampled data (1 kHz ) please see (in .mat format):



	
Experiment 1 : https://doi.org/10.5281/zenodo.8401160
	
Experiment 2 : https://doi.org/10.5281/zenodo.3840617 



 


Code used to import, process, and plot this dataset can be found here:



	
GitHub : https://github.com/ngebodh/GX_tES_EEG_Physio_Behavior



 


Additional figures for this project have been shared on Figshare. Trial-wise figures can be found here:



	
PSD: https://doi.org/10.6084/m9.figshare.14810517.v1
	
Topoplots During Stimulation: https://doi.org/10.6084/m9.figshare.14810478
	
Voltage timeseries, spectrogram and behavior: https://doi.org/10.6084/m9.figshare.14810442.v1



 


The full dataset is also provided in BIDS format here:



	
Data in BIDS format: https://doi.org/10.18112/openneuro.ds003670.v1.1.0



Data License 
Creative Common 4.0 with attribution (CC BY 4.0)


 


NOTE


Please email ngebodh01@citymail.cuny.edu with any questions.


Follow @NigelGebodh for latest updates.
 


 



Updates



	
Version 2 

	

		
Stimulation trigger labels now adjusted. Previous labels were missmatched for Experiment 1's data.